Okta, Inc. <OKTA.O>: Raymond James Raises Target Price to $185 From $115
OKTA•Related News
Revolution Medicines, Inc. <RVMD.O>: Oppenheimer raises target price to $260 from $230
RVMD•
Shipping traffic at key Gulf waterways remain subdued, data shows
XLE•
C.H. Robinson Edge Report flags tightening freight capacity as transportation costs rise
CHRW•
KKR settles US antitrust case accusing it of merger filing violations for $250 million
KKR•
Nvidia Corporation <NVDA.O>: Melius Research Raises Target Price to $420 From $400
NVDA•